Biocad Sues Roche Over Alleged Predatory Pricing Practices of Biosimilars
Biopharmaceutical firm Biocad has filed suit against Roche and its Genentech subsidiary over their alleged use of predatory pricing practices in Russia to decimate the sales of the Russian drugmaker’s biosimilars.
Source: Generic Line